Medical device manufacturer Prollenium has acquired microcannula brand SoftFil.
According to the company, there are 23 different SoftFil cannula lengths for the face and body, which contain markers to help locate the tip with a red dot to indicate where the product will emerge.
CEO of SoftFil, Dr Sandrine Sebban, said, “Prollenium is certainly building a strong aesthetic empire with its acquisition of SoftFil, designed to push the borders of innovation to achieve beautiful, precise but most importantly safe results. Prollenium’s dermal filler brand Revanesse’s safety profile is impressive and its unique qualities certainly make it a filler of the future and I like all things committed to innovation and the betterment of the aesthetics industry.”
